Qiagen NV

NYSE:QGEN  
48.26
+0.42 (+0.88%)
Products

Qiagen NV launches NEUMODX Multiplex SARS-COV-2 test in Europe

Published: 11/16/2020 21:15 GMT
Qiagen NV (QGEN) - Qiagen Launches Neumodx Multiplex Test to Complete Range of Sars-cov-2 Testing Solutions in Europe and Other Markets.
Fast and Easy-to-use Respiratory Pcr Test Comes Onto Market As Flu Season Gains Pace in Northern Hemisphere.
Ce-ivd Marking in Europe Granted for Neumodx™ Flu A-b/rsv/sars-cov-2 Vantage Test, Has Also Been Submitted to FDA for Emergency Use Authorization.
Test Adds to Qiagen's Growing Portfolio of Pcr Testing Solutions for Covid-19 Testing.
Qiagen Also Expands Sample Type Claim for Neumodx™ Sars-cov-2 Test to Include Saliva From a Dedicated Collection Kit in Europe.